InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
4
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+75.6%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Ferguson Matthew, 首席财务官. Officer active across 2 companies, notably Aziyo Biologics, INC.. Cumulatively, 21 disclosures have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €64k. Activity tracked since 10 May 2021. The latest transaction was disclosed on 10 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Ferguson Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
12,500 股Class A Common StockSEC:0001304079-26-000010:0
4,486 股@ US$0.80Class A Common StockSEC:0001304079-26-000010:1
12,500 股Class A Common StockSEC:0001304079-26-000005:0
60,000 股@ US$0.5316.1% 占其流量Class A Common StockSEC:0001304079-25-000008:0
标准退出：2026年3月17日 (T+90)
12,500 股Class A Common StockSEC:0001304079-25-000006:0
4,500 股@ US$0.651.8% 占其流量Class A Common StockSEC:0001304079-25-000004:0
标准退出：2026年3月1日 (T+90)
29,000 股Class A Common StockSEC:0001410578-25-002228:0
12,500 股Class A Common StockSEC:0001415889-25-016993:0
1,287 股Class A Common StockSEC:0001415889-25-007697:0
12,500 股Class A Common StockSEC:0001415889-24-028994:0
29,500 股Class A Common StockSEC:0001415889-24-023299:0
50,000 股Class A Common StockSEC:0001415889-24-021194:0
105,080 股@ US$1.4275100.0% 占其流量Class A Common StockSEC:0001415889-24-020441:0
25,000 股Class A Common StockSEC:0001415889-24-016513:0
1,288 股0Class A Common StockSEC:0001415889-24-007995:0
70,053 股Class A Common StockSEC:0001415889-23-013473:0
1,287 股0Class A Common StockSEC:0001415889-23-004624:0
6,000 股@ US$4.0349.0% 占其流量Class A Common StockSEC:0001415889-22-012089:0
标准退出：2023年3月2日 (T+90)
13,874 股Class A Common StockSEC:0001415889-22-009542:0
1,288 股0Class A Common StockSEC:0001415889-22-002860:0
1,300 股@ US$11.1434.2% 占其流量Class A Common StockSEC:0001104659-21-065258:0
标准退出：2021年8月8日 (T+90)
21 条申报中的 21 条
About Ferguson Matthew
Ferguson Matthew is Chief Financial Officer and has filed 19 transactions in total. In the 19 recent filings sampled, the period runs from 2021-05-12 to 2026-03-12, with EUR 64481 of purchases and EUR 0 of sales, and the most frequent transaction nature is option exercise. He is reported at ELUTIA INC. and Aziyo Biologics, INC.
